KMC Speciality Hospitals Gears Up for Q3 Reveal on 11th February; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q3 Results 

KMC Speciality Hospitals ‘s Q3 results FY26 are scheduled to be announced on 11th February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

KMC Speciality Hospitals Q3 Results 2026 Preview

• KMC Speciality Hospitals’ revenue is expected to be in the range of ₹61.36 crore, a 9.13% YoY increase. 
• Profit After Tax, or PAT, is projected to rise 93.45% YoY. 
• Net profit is ₹7.51 crore, up 93.45% YoY 
• EBITDA to rise 47.48%

KMC Speciality Hospitals Share Performance 

• Over the past six months, KMC Speciality Hospitals’ share price has risen by 38.56% to ₹79.77.
• Moreover, over the past year, the stock has increased by 8.99%.
• Despite this weak short-term performance, KMC Speciality Hospitals’ stock has delivered a financially sound 240.90% return over the past 5 years.
• As of 10th February 2026, the stock traded at ₹79.77 per share.

Key Factors to Watch for KMC Speciality Hospitals  Q3 Results FY26

• Revenue & Patient Volume: Growth from higher patient footfall, surgeries, and service realisation.
• Profitability & Margins: EBITDA and PAT trends amid operating and interest cost pressures.
• Occupancy & ARPOB: Hospital occupancy rates and average revenue per occupied bed.
• Cost & Financial Efficiency: Management of interest costs, working capital, and overall cost control.
• Expansion & Capacity Growth: Contribution from new beds, facilities, and strategic expansion plans.

Final Thoughts

KMC Speciality Hospitals will announce its Q3 FY26 results on 11th February 2026. Analysts expect 9.13% revenue growth, a 93.45% rise in PAT, and a 47.48% rise in EBITDA. KMC Speciality Hospitals focuses on patient volume and revenue growth, margin trends, occupancy and ARPOB, cost and working capital management, and contribution from new facilities or bed expansions.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Alfred Herbert India Ltd Q3 Results FY26 Preview: PAT falls 3%

Salora International Q3 Results FY26 Preview: PAT falls 18.54%

Kuantum Papers Q3 Results FY26 Preview: PAT falls 29.85%

AK Capital Services Ltd Q3 Results FY26 Preview: PAT falls 16.86%

Glance Finance Q3 Results FY26 Preview: PAT rises 58.48%